NOVEL FORMS OF [R-(R,R)]-2-(4-FLUOROPHENYL)-B,B-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPT ANOIC ACID MAGNESIUM

Novel forms of atorvastatin magnesium salt designated Form A, Form B, Form C, Form D, Form E, and Form F, pharmaceutical compositions containing such compounds, methods for their preparation and methods utilizing the compounds for treatment of hyperlipidemia, hypercholesterolemia, osteoporosis, beni...

Full description

Saved in:
Bibliographic Details
Main Authors MILLER, JONATHAN, MARK, LEONARD, JASON, ALBERT
Format Patent
LanguageEnglish
French
Published 24.05.2007
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Novel forms of atorvastatin magnesium salt designated Form A, Form B, Form C, Form D, Form E, and Form F, pharmaceutical compositions containing such compounds, methods for their preparation and methods utilizing the compounds for treatment of hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease are described. La présente invention concerne de nouvelles formes du sel de magnésium d'atorvastatine appelées Forme A, Forme B, Forme C, Forme D, Forme E et Forme F, des compositions pharmaceutiques contenant ces composés, des procédés pour leur préparation et des procédés utilisant ces composés pour le traitement de l'hyperlipidémie, l'hypercholestérolémie, l'ostéoporose, l'hyperplasie bénigne de la prostate (HBP) et la maladie d'Alzheimer.
Bibliography:Application Number: WO2006IB03239